The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...

Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The vaccine's prospects were thrown into doubt after the U.S. Food and Drug Administration missed its April 1 target to ...

President Donald Trump announced that Dr. Casey Means, who has close ties to the secretary of health and human services, will ...

Biologist Bret Weinstein told Daily Caller News Foundation co-founder Tucker Carlson on Wednesday that he believes the White ...

Moderna conducted a study to test a combination COVID-19 and flu shot. Researchers tested the shot on 8,000 adults. The pharmaceutical and biotechnology company is targeting 2026 for approval of ...